A Study of Tooth Erosion in People With Esophagogastric Cancer
Pilot Study of Dental Erosion as a Non-invasive Biomarker of Esophagogastric Cancer
1 other identifier
interventional
174
1 country
1
Brief Summary
The researchers are doing this study to find out more about what may lead to the loss of tooth enamel (the thin outer covering of the tooth) and how often it happens in people with esophagogastric cancer, colorectal cancer, pancreatic cancer, breast cancer, head and neck cancer, or non-small cell lung cancer, or a healthy volunteer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 3, 2022
CompletedStudy Start
First participant enrolled
November 3, 2022
CompletedFirst Posted
Study publicly available on registry
November 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2027
March 23, 2026
March 1, 2026
5 years
November 3, 2022
March 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The incidence of dental erosions
scored with a modified BEWE index.
1 year
Study Arms (3)
Patients diagnosed with esophagogastric cancer
EXPERIMENTALPatients have completed the intervention once completing the survey, undergoing dental imaging and future patients will also provide an optional saliva sample.
Patients diagnosed with colorectal, pancreatic, breast, head and neck, or non-small cell lung cancer
EXPERIMENTALPatients undergo consenting and dental imaging during their routine visits at MSK.
Healthy volunteers who have not been diagnosed with cancer
EXPERIMENTALHealthy controls will be defined as those without a known or suspected invasive cancer history and excluding those undergoing a procedure for symptomatic reflux.
Interventions
Intraoral pictures of molars and incisors in 13 key regions
Cohort 1 only. Participant is responsible for collecting and bringing the salvia sample to clinic.
This is a 15-item questionnaire. The questionnaire asks subjects to quantify, during a specified duration of time, the number of times they have consumed or completed a task (ex. alcohol intake, cigarette use, and teeth brushing frequency). Additionally, the questionnaire further asks subjects to quantify their GERD symptoms and risk factors prior to diagnosis. All study procedures will be completed in one visit as part of a standard-of-care clinic visit.
Eligibility Criteria
You may qualify if:
- Subject is willing and able to provide written informed consent.
- Patients with a history of esophagogastric, HNSCC, PDAC, CRC, or NSCLC or healthy controls
- Patients must be able to fully comprehend and complete the survey and be willing to have pictures taken of their teeth with a camera or intra-oral camera.
- Patients must be able to understand English language or have access to adequate translation services.
- Age ≥ 18 years old.
You may not qualify if:
- Subjects without evaluable molars or with significant molar dental work precluding dentists from assessing enamel status, Note: evaluable is defined as having bilateral assessable mandibular molars, or erosions present in the remaining assessable quadrants.
- For healthy controls only, patients cannot have a non-skin cancer history nor presenting for a procedure evaluating reflux symptoms.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven Maron, MD
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2022
First Posted
November 10, 2022
Study Start
November 3, 2022
Primary Completion (Estimated)
November 1, 2027
Study Completion (Estimated)
November 1, 2027
Last Updated
March 23, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org